Brief: 3Sbio Says Phase III Clinical Trial Of 5% Minoxidil Foam Reached Preset End Point

3SBio

30/08/2021 11:54

Aug 30 (Reuters) - 3SBio Inc  1530.HK :
    * PHASE III CLINICAL TRIAL OF 5% MINOXIDIL FOAM REACHED
PRESET END
POINT
    * PLANS TO SUBMIT NDA TO NMPA IN Q4


Further company coverage:  1530.HK 

 ((Reuters.Briefs@thomsonreuters.com;))